285 related articles for article (PubMed ID: 24763434)
1. Rapamycin inhibition of polyposis and progression to dysplasia in a mouse model.
Hardiman KM; Liu J; Feng Y; Greenson JK; Fearon ER
PLoS One; 2014; 9(4):e96023. PubMed ID: 24763434
[TBL] [Abstract][Full Text] [Related]
2. Novel read through agent: ZKN-0013 demonstrates efficacy in APC
Graf MR; Apte S; Terzo E; Padhye S; Shi S; Cox MK; Clark RB; Modur V; Badarinarayana V
J Mol Med (Berl); 2023 Apr; 101(4):375-385. PubMed ID: 36808265
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin Extends Life Span in Apc
Parihar M; Dodds SG; Hubbard G; Javors MA; Strong R; Hasty P; Sharp ZD
Clin Colorectal Cancer; 2021 Mar; 20(1):e61-e70. PubMed ID: 33132009
[TBL] [Abstract][Full Text] [Related]
4. Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc(min) mice.
Xiao H; Yin W; Khan MA; Gulen MF; Zhou H; Sham HP; Jacobson K; Vallance BA; Li X
Gastroenterology; 2010 Aug; 139(2):574-85. PubMed ID: 20416302
[TBL] [Abstract][Full Text] [Related]
5. The effect of a germline mutation in the APC gene on β-catenin in human embryonic stem cells.
Yedid N; Kalma Y; Malcov M; Amit A; Kariv R; Caspi M; Rosin-Arbesfeld R; Ben-Yosef D
BMC Cancer; 2016 Dec; 16(1):952. PubMed ID: 28010732
[TBL] [Abstract][Full Text] [Related]
6. miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
Prossomariti A; Piazzi G; D'Angelo L; Miccoli S; Turchetti D; Alquati C; Montagna C; Bazzoli F; Ricciardiello L
Mol Cancer Res; 2018 Dec; 16(12):1965-1976. PubMed ID: 30072583
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic mutations in adenomatous polyposis coli (Apc) activate mechanistic target of rapamycin complex 1 (mTORC1) in mice and zebrafish.
Valvezan AJ; Huang J; Lengner CJ; Pack M; Klein PS
Dis Model Mech; 2014 Jan; 7(1):63-71. PubMed ID: 24092877
[TBL] [Abstract][Full Text] [Related]
8. Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis.
Hu PJ; Knoepp SM; Wu R; Cho KR
Genes Chromosomes Cancer; 2012 Mar; 51(3):283-9. PubMed ID: 22120905
[TBL] [Abstract][Full Text] [Related]
9. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.
Gaspar C; Franken P; Molenaar L; Breukel C; van der Valk M; Smits R; Fodde R
PLoS Genet; 2009 Jul; 5(7):e1000547. PubMed ID: 19578404
[TBL] [Abstract][Full Text] [Related]
10. Elevated adenomatous polyposis coli in goblet cells is associated with inflammation in mouse and human colon.
Gomez CL; Neufeld KL
Exp Physiol; 2020 Dec; 105(12):2154-2167. PubMed ID: 33150708
[TBL] [Abstract][Full Text] [Related]
11. Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing.
Crespo M; Vilar E; Tsai SY; Chang K; Amin S; Srinivasan T; Zhang T; Pipalia NH; Chen HJ; Witherspoon M; Gordillo M; Xiang JZ; Maxfield FR; Lipkin S; Evans T; Chen S
Nat Med; 2017 Jul; 23(7):878-884. PubMed ID: 28628110
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
13. Claudin-1 overexpression in intestinal epithelial cells enhances susceptibility to adenamatous polyposis coli-mediated colon tumorigenesis.
Pope JL; Ahmad R; Bhat AA; Washington MK; Singh AB; Dhawan P
Mol Cancer; 2014 Jul; 13():167. PubMed ID: 24997475
[TBL] [Abstract][Full Text] [Related]
14. Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling.
Zhang J; Cao H; Zhang B; Cao H; Xu X; Ruan H; Yi T; Tan L; Qu R; Song G; Wang B; Hu T
J Cell Mol Med; 2013 Nov; 17(11):1484-93. PubMed ID: 24015932
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice.
Liu HP; Gao ZH; Cui SX; Wang Y; Li BY; Lou HX; Qu XJ
Int J Cancer; 2013 Jun; 132(11):2667-81. PubMed ID: 23132636
[TBL] [Abstract][Full Text] [Related]
16. Familial Adenomatous Polyposis; Succesful Use of Sirolimus.
Yuksekkaya H; Yucel A; Gumus M; Esen H; Toy H
Am J Gastroenterol; 2016 Jul; 111(7):1040-1. PubMed ID: 27356835
[No Abstract] [Full Text] [Related]
17. Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis.
Gaspar C; Cardoso J; Franken P; Molenaar L; Morreau H; Möslein G; Sampson J; Boer JM; de Menezes RX; Fodde R
Am J Pathol; 2008 May; 172(5):1363-80. PubMed ID: 18403596
[TBL] [Abstract][Full Text] [Related]
18. A knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression.
Zeineldin M; Cunningham J; McGuinness W; Alltizer P; Cowley B; Blanchat B; Xu W; Pinson D; Neufeld KL
Oncogene; 2012 May; 31(19):2423-37. PubMed ID: 21996741
[TBL] [Abstract][Full Text] [Related]
19. Targeted next-generation sequencing approach for molecular genetic diagnosis of hereditary colorectal cancer: Identification of a novel single nucleotide germline insertion in adenomatous polyposis coli gene causes familial adenomatous polyposis.
Wang D; Liang S; Zhang X; Dey SK; Li Y; Xu C; Yu Y; Li M; Zhao G; Zhang Z
Mol Genet Genomic Med; 2019 Jan; 7(1):e00505. PubMed ID: 30523670
[TBL] [Abstract][Full Text] [Related]
20. Supplementation with phytoestrogens and insoluble fibers reduces intestinal carcinogenesis and restores ER-β expression in Apc-driven colorectal carcinogenesis.
Luceri C; Femia AP; Tortora K; D'Ambrosio M; Fabbri S; Fazi M; Caderni G
Eur J Cancer Prev; 2020 Jan; 29(1):27-35. PubMed ID: 31651566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
